Cellectar BioSciences, Inc.
(NASDAQ : CLRB)

( )
CLRB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading CLRB News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.80%70.501.0%$928.99m
AMGNAmgen Inc.
0.90%176.130.8%$640.16m
BIIBBiogen Inc.
2.10%291.130.9%$505.62m
CELGCelgene Corporation
3.00%121.781.0%$476.20m
INCYIncyte Corporation
2.14%134.022.3%$444.12m
REGNRegeneron Pharmaceuticals, Inc.
3.34%373.051.9%$336.26m
ALXNAlexion Pharmaceuticals, Inc.
0.50%132.202.0%$304.94m
TSROTESARO, Inc.
0.28%187.4215.3%$167.36m
ILMNIllumina, Inc.
4.26%166.823.9%$151.47m
EXELExelixis, Inc.
6.46%23.095.5%$141.95m
VRTXVertex Pharmaceuticals Incorporated
3.29%88.902.6%$133.58m
CLVSClovis Oncology, Inc.
5.22%60.9216.4%$122.35m
AAgilent Technologies, Inc.
-0.16%51.661.7%$108.92m
BMRNBioMarin Pharmaceutical Inc.
4.70%91.623.9%$100.60m
ACADACADIA Pharmaceuticals Inc.
2.50%39.8519.0%$100.51m

Company Profile

Cellectar BioSciences, Inc. operates as a biopharmaceutical company. It engages developing phospholipid drug conjugates designed to provide cancer targeted delivery of oncologic payloads to cancer stem cells. The company was founded on April 11, 2011 and is headquartered in Madison, WI.